Mural Oncology Statistics

Total Valuation

Mural Oncology has a market cap or net worth of $63.97 million. The enterprise value is -$192.13 million.

Market Cap	63.97M
Enterprise Value	-192.13M

Important Dates

The next estimated earnings date is Monday, May 20, 2024, before market open.

Earnings Date	May 20, 2024
Ex-Dividend Date	n/a

Share Statistics

Mural Oncology has 16.92 million shares outstanding. The number of shares has increased by 0.00% in one year.

Shares Outstanding	16.92M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.24
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.56, with a Debt / Equity ratio of 0.06.

Current Ratio	9.56
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -171.30% and return on invested capital (ROIC) is -70.38%.

Return on Equity (ROE)	-171.30%
Return on Assets (ROA)	-123.70%
Return on Capital (ROIC)	-70.38%
Revenue Per Employee	n/a
Profits Per Employee	-$1.77M
Employee Count	117
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Mural Oncology has paid $12.16 million in taxes.

Income Tax	12.16M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (1Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	4.35
200-Day Moving Average	n/a
Relative Strength Index (RSI)	41.98
Average Volume (30 Days)	227,516

Short Selling Information

The latest short interest is 1.72 million, so 10.16% of the outstanding shares have been sold short.

Short Interest	1.72M
Short Previous Month	1.33M
Short % of Shares Out	10.16%
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-196.24M
Pretax Income	-195.29M
Net Income	-207.45M
EBITDA	-192.72M
EBIT	-195.29M
Earnings Per Share (EPS)	-$12.43

Full Income Statement

Balance Sheet

The company has $271.11 million in cash and $15.01 million in debt, giving a net cash position of $256.10 million or $15.13 per share.

Cash & Cash Equivalents	271.11M
Total Debt	15.01M
Net Cash	256.10M
Net Cash Per Share	$15.13
Equity / Book Value	263.82M
Book Value Per Share	15.59
Working Capital	248.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$194.25 million and capital expenditures -$3.45 million, giving a free cash flow of -$197.70 million.

Operating Cash Flow	-194.25M
Capital Expenditures	-3.45M
Free Cash Flow	-197.70M
FCF Per Share	-$11.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mural Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	-324.30%
FCF Yield	-309.07%

Analyst Forecast

The average price target for Mural Oncology is $13.00, which is 243.92% higher than the current price. The consensus rating is "Buy".

Price Target	$13.00
Price Target Difference	243.92%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1